Figure 2.
The estimated proportion of women who were nonadherent based on plasma dapivirine (DPV) levels, by baseline general ring worry (RW) and enrollment pre-/post adherence monitoring intervention among women using a dapivirine ring in the ASPIRE trial (N=1,270). Estimates are from mixed-effect logistic regression model adjusting for age group, country, and time in study.